Pre-operative peripheral intravenous cannula insertion failure at the first attempt in adults: Development of the VENSCORE predictive scale and identification of risk factors.


Journal

Journal of clinical anesthesia
ISSN: 1873-4529
Titre abrégé: J Clin Anesth
Pays: United States
ID NLM: 8812166

Informations de publication

Date de publication:
12 2021
Historique:
received: 11 01 2021
revised: 07 06 2021
accepted: 24 06 2021
pubmed: 26 7 2021
medline: 27 1 2022
entrez: 25 7 2021
Statut: ppublish

Résumé

Our objective was to develop a clinical scale (the VENSCORE) to predict pre-operative peripheral intravenous cannula (PIVC) insertion failure at the first attempt in adults. This was a prospective multicenter cohort study that included internal validation with bootstrapping. The operating rooms of 14 hospitals in southern France from June 2016 to June 2018. Consecutive adult patients aged 18 years or older were recruited upon arrival to the operating room, regardless of American Society of Anaesthesiology (ASA) physical status. PIVC insertion on arrival to the OR. PIVC insertion failure at the first attempt was the outcome of interest. Data collected included the number of PIVC insertion attempts and potential predictors of the risk of failure (including pre-operative patient characteristics and data relative to the procedure). Uni- and multivariable logistic analyses were performed. Based on these results, the VENSCORE scale was developed to predict the risk of failure of the first PIVC insertion. In total, 3394 patients were included, and 27 were excluded because of protocol violations. The PIVC insertion failure rate at the first attempt was 20.3%. Based on multivariable analysis, a history of difficult PIVC insertions, high-risk surgery, poor vein visibility, and moderate to poor vein palpability were identified as risk factors for insertion failure at the first attempt. The area under the curve of the predictive model was 0.82 (95% confidence interval: 0.80-0.84). A VENSCORE value of 0 points was associated with a failure rate of 7%, versus 97% for a score of 6. The four-item VENSCORE scale could be useful for prospectively identifying adults at risk of first PIVC insertion attempt failure.

Identifiants

pubmed: 34303989
pii: S0952-8180(21)00275-0
doi: 10.1016/j.jclinane.2021.110435
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

110435

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Emeline Angles (E)

CHU Bordeaux, Service d'Anesthésie Réanimation Pellegrin, Hôpital Pellegrin, Place Amélie Raba Léon, F-33000 Bordeaux, France.

Florian Robin (F)

CHU Bordeaux, Service d'Anesthésie Réanimation Pellegrin, Hôpital Pellegrin, Place Amélie Raba Léon, F-33000 Bordeaux, France; Univ. Bordeaux, INSERM U12-11, Laboratoire de Maladies Rares: Génétique et Métabolisme (MRGM), 176 Rue Léo Saignat, F-33000 Bordeaux, France.

Bertrand Moal (B)

CHU de Bordeaux, Pôle de santé publique, Service d'Information Médicale, F-33000 Bordeaux, France; Univ. Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health, F-33000 Bordeaux, France; INSERM, ISPED, Centre INSERM U1219-Bordeaux Population Health, F-33000 Bordeaux, France.

Maxim Roy (M)

CHU Bordeaux, Service d'Anesthésie Réanimation Pellegrin, Hôpital Pellegrin, Place Amélie Raba Léon, F-33000 Bordeaux, France; Department of anesthesiology, CHUM, Montreal, Canada.

Musa Sesay (M)

CHU Bordeaux, Service d'Anesthésie Réanimation Pellegrin, Hôpital Pellegrin, Place Amélie Raba Léon, F-33000 Bordeaux, France.

Alexandre Ouattara (A)

CHU Bordeaux, Department of Anaesthesia and Critical Care, Magellan Medico-Surgical Center, F-33000 Bordeaux, France; Univ. Bordeaux, INSERM, UMR 1034, , Biology of Cardiovascular Diseases, F-33600 Pessac, France.

Matthieu Biais (M)

CHU Bordeaux, Service d'Anesthésie Réanimation Pellegrin, Hôpital Pellegrin, Place Amélie Raba Léon, F-33000 Bordeaux, France; Univ. Bordeaux, INSERM, UMR 1034, , Biology of Cardiovascular Diseases, F-33600 Pessac, France.

Stéphanie Roullet (S)

CHU Bordeaux, Service d'Anesthésie Réanimation Pellegrin, Hôpital Pellegrin, Place Amélie Raba Léon, F-33000 Bordeaux, France; Univ. Bordeaux, INSERM, UMR 1034, , Biology of Cardiovascular Diseases, F-33600 Pessac, France.

Florence Saillour-Glénisson (F)

CHU de Bordeaux, Pôle de santé publique, Service d'Information Médicale, F-33000 Bordeaux, France; Univ. Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health, F-33000 Bordeaux, France; INSERM, ISPED, Centre INSERM U1219-Bordeaux Population Health, F-33000 Bordeaux, France.

Karine Nouette-Gaulain (K)

CHU Bordeaux, Service d'Anesthésie Réanimation Pellegrin, Hôpital Pellegrin, Place Amélie Raba Léon, F-33000 Bordeaux, France; Univ. Bordeaux, INSERM U12-11, Laboratoire de Maladies Rares: Génétique et Métabolisme (MRGM), 176 Rue Léo Saignat, F-33000 Bordeaux, France; CHU de Bordeaux, Ecole d'infirmères d'anesthésie, F-33000 Bordeaux, France. Electronic address: karine.nouette-gaulain@u-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH